Adjuvant Lung Cancer – Roy Herbst, MD and Robert Figlin, MD discuss the recent ASCO20 plenary presentation of the ADAURA study investigating the use of Tagrisso (osimertinib) in the adjuvant setting for NSCLC EGFR+ patients - a podcast by OBR Peer-Spectives
from 2020-06-25T15:47:52
::
::
Roy Herbst, MD and Robert Figlin, MD discuss the implications of the recent ASCO20 presentation of the ADAURA study investigating the use of Tagrisso (osimertinib) in Stage I-III EGFR+ NSCLC patients
Further episodes of OBR Peer-Spectives
Further podcasts by OBR Peer-Spectives
Website of OBR Peer-Spectives